Results 21 to 30 of about 3,215 (175)

An assessment of the efficacy and safety of dydrogesterone in women with ovarian endometrioma: An open‐label multicenter clinical study

Reproductive Medicine and Biology, 2021
Purpose To assess the efficacy and safety of dydrogesterone in Japanese women with ovarian endometrioma in a real‐world setting. Methods The post‐marketing study involved 15 sites in Japan.
Jo Kitawaki, Kaori Koga, Takumi Kanzo, Mikio Momoeda   +3 more
doaj   +1 more source

Endometrial polyps: new strategies for effective treatment

Репродуктивная эндокринология, 2017
The work is devoted to the issue of effectiveness improvement in treatment of endometrial polyps (EP) in women of reproductive age. Study objective: to evaluate the clinical efficacy of the Allokin-alpha in combination with dydrogesterone for the ...
Т. Ф Татарчук, Д. Г. Герман   +1 more
doaj   +1 more source

Real-world utilization pattern of dydrogesterone in 7287 Indian women with obstetric and gynecological conditions: data from multicentric, retrospective study

Revista Brasileira de Ginecologia e Obstetrícia
Objective: Despite the literature on dydrogesterone, studies on dydrogesterone utilization patterns are largely lacking in Indian patients. Methods: This was a multi-center, retrospective, observational, cross-sectional, and descriptive study across 817
Jaydeep Tank, Sanjay Gupte, Purna Chandra Mahapatra, Jayanthi Reddy, Pratima Mittal, Ashish Kumar Mukhopadhyay, Lila Vyas, Achla Batra, Mahesh Gupta, Sunita Tandulwadkar, Sunita Chandra, Vidya Bhat, Kawita Bapat, Parikshit Tank, Ketan Kulkarni, Onkar Swami   +15 more
doaj   +1 more source

Evaluation of Femoston and Dydrogesterone therapy for incomplete abortion: a retrospective cohort study

Gynecological Endocrinology
Purpose This study aimed to compare the efficacies of Femoston and Dydrogesterone therapy in patients with incomplete abortions.Methods Patients with incomplete abortions were included if they preferred medication over surgical intervention.
Xueyao Huang, Bingchen Gong, Yingying Cai, Wenrong Wang, Jian An   +4 more
doaj   +1 more source

Dydrogesterone as an oral alternative to vaginal progesterone for IVF luteal phase support: A systematic review and individual participant data meta-analysis.

PLoS ONE, 2020
The aim of this systematic review and meta-analysis was to conduct a comprehensive assessment of the evidence on the efficacy and safety of oral dydrogesterone versus micronized vaginal progesterone (MVP) for luteal phase support. Embase and MEDLINE were
Georg Griesinger, Christophe Blockeel, Elke Kahler, Claire Pexman-Fieth, Jan I Olofsson, Stefan Driessen, Herman Tournaye   +6 more
doaj   +1 more source

Progestin-related breast volume changes in a woman with complete androgen insensitivity syndrome (CAIS)

Endocrinology, Diabetes & Metabolism Case Reports, 2023
A 31-year-old woman with complete androgen insensitivity syndrome (CAIS) experienced breast volume fluctuations during biphasic hormone replacement therapy consisting of estradiol and cyclical dydrogesterone, a progestin.
Benthe A M Dijkman, Christel J M de Blok, Koen M A Dreijerink, Martin den Heijer   +3 more
doaj   +1 more source

Comparison of oral Dydrogesterone and 17-α hydroxyprogesterone caprate in the prevention of preterm birth

BMC Pregnancy and Childbirth, 2022
Background Preterm birth (PTB) remains a significant problem in obstetric care. Progesterone supplements are believed to reduce the rate of preterm labor, but formulation, type of administration, and dosage varies in different studies.
Fahimeh Alizadeh, Malihe Mahmoudinia, Masoumeh Mirteimoori, Lila pourali, Shabnam Niroumand   +4 more
doaj   +1 more source

Successful pregnancy: simply about the complicated

Репродуктивная эндокринология
Progesterone is a key hormone essential for maintaining pregnancy. Its deficiency can lead to the risk of miscarriage, recurrent pregnancy loss, and unsuccessful attempts at in vitro fertilization.
T.F. Tatarchuk, V.I. Pyrogova, N.P. Goncharuk, N.Y. Pedachenko, D.G. Konkov   +4 more
doaj   +1 more source

The effects of menopausal hormone therapy on proinflammatory cytokines and immunoglobulins in perimenopausal patients with type 2 diabetes mellitus and chronic obstructive pulmonary disease (COPD) [PDF]

Терапевтический архив, 2018
Aim. To determine the effects of menopausal hormone therapy dosage on levels of proinflammatory cytokines and immunoglobulins in bodily fluids of patients with type 2 diabetes mellitus (DM) and chronic obstructive pulmonary disease (COPD) during ...
A S Panevina, N S Smetneva, A M Vasilenko, M V Shestakova   +3 more
doaj   +1 more source

Menopausal hormone therapy and comprehensive postmenopausal care in gynecologic cancer survivors: A position paper from the FIGO Committee on Women at Menopausal Age

International Journal of Gynecology &Obstetrics, EarlyView.
Abstract Recent advances in cancer screening, diagnosis, and treatment have greatly improved survival rates among women with gynecologic cancers. More survivors now live long enough to experience treatment‐related menopause. Vasomotor symptoms, genitourinary syndrome of menopause, sexual dysfunction, sleep issues, and long‐term risks from estrogen ...
Agnaldo Lopes da Silva‐Filho, Suvarna Khadilkar, Hema Divakar, Chiara Benedetto, Andrea R. Genazzani, Diana Ramos, Elizabete Argale, Enrique Herrera, Martha Hickey   +8 more
wiley   +1 more source